摘要
目的:探讨临床Ⅰ期子宫内膜癌患者使用诊断性宫腔镜的安全性,是否增加腹水细胞学的阳性率及对预后的影响。方法:回顾性分析本院52例术前宫腔镜诊断为临床Ⅰ期子宫内膜癌患者的临床资料,了解术中腹水细胞学检查、手术方式、手术病理分期等,随访预后。结果:宫腔镜距离开腹手术的平均时间间隔是36天(5～82天),腹水细胞学阳性率2/52(3.8%),平均生存时间81个月(9～130个月),5年生存率91.5%。结论:诊断性宫腔镜未增加临床Ⅰ期子宫内膜癌患者阳性腹水细胞学的风险,亦未对预后造成不良影响。
Objective： To explore the safety ot using diagnostic nystemscopy in patients with clinical stage one endometrial cancer,whether diagnostic hystemscopy can increases the risk of positive peritoneal cytology in such patients and affects their post-operative prognosis. Methods： Medical records of 52 patients with clinical stage one endometrial cancer diagnosed by pre-operative hysteroscopy in our hospital were reviewed in this retrospective study, informations about cytological test of abdominal peritoneal fluid, type of operation,post-operative surgical stage and follow-up were collected. Results： The mean interval between hysteroscopy and laparotomy was 36 days（5-82d）, 2/52 （3.8%） present positive peritoneal cytology, the mean survival time was 81 months （9-130m）, the 5-year survival rate was 91.5 %. Cool, ion： Diagnostic hysteroscopy had not increase the risk of positive peritoneal cytology,also had no adverse effect on prognosis in clinical stage one endometrial cancer patients.
出处
《重庆医科大学学报》
CAS
CSCD
2006年第3期408-410,共3页
Journal of Chongqing Medical University
关键词
子宫内膜癌
诊断性宫腔镜
腹水细胞学
预后
Endometrial cancer
Diagnostic hysteroscopy
Peritoneal Cytology
Prognosis
